Management of poor-prognosis or relapsed germ-cell cancer.
about
Is high dose therapy superior to conventional dose therapy as initial treatment for relapsed germ cell tumors? The TIGER Trial.Delayed rhabdomyolysis with paclitaxel, ifosfamide, carboplatin, and etoposide regimen: a case report.Plerixafor is effective and safe for stem cell mobilization in heavily pretreated germ cell tumor patients.
P2860
Management of poor-prognosis or relapsed germ-cell cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Management of poor-prognosis or relapsed germ-cell cancer.
@en
Management of poor-prognosis or relapsed germ-cell cancer.
@nl
type
label
Management of poor-prognosis or relapsed germ-cell cancer.
@en
Management of poor-prognosis or relapsed germ-cell cancer.
@nl
prefLabel
Management of poor-prognosis or relapsed germ-cell cancer.
@en
Management of poor-prognosis or relapsed germ-cell cancer.
@nl
P1433
P1476
Management of poor-prognosis or relapsed germ-cell cancer.
@en
P2093
Gedske Daugaard
P304
P356
10.1111/J.1464-410X.2009.08865.X
P433
P577
2009-11-01T00:00:00Z